Amneal Pharmaceuticals(DE:2DT)
€18.60+0.20 (+1.09%)
DE:2DT
Amneal Pharmaceuticals earnings date
€18.60
At close:+0.20 (+1.09%)
Amneal Pharmaceuticals (2DT) Q2 2023 Earnings Report
2 Followers
DE:2DT Q2 2023 EPS Results
- Actual EPS
- EUR 0.17
- Consensus EPS
- EUR 0.09
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- EUR 0.17
DE:2DT Q2 2023 Revenue Results
- Actual Revenue
- EUR 534.38M
- Expected Revenue
- EUR 504.13M
- Beat/Miss
- Beat by +EUR 30.25M
- YoY Revenue Growth
- +7.10%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/04/2023
- Time
- Before Open
- Conference Call
- Friday, August 4, 2023
DE:2DT Upcoming Earnings
Amneal Pharmaceuticals's next earnings date is estimated for February 26, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:2DT Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2DT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 26, 2027 | 2026 (Q4) | 0.21- | 0.19 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.210.23 | 0.15 | 52.94% (+0.08) | |
| Jul 30, 2026 | 2026 (Q2) | 0.200.27 | 0.22 | 20.00% (+0.04) | |
| May 07, 2026 | 2026 (Q1) | 0.150.24 | 0.19 | 28.57% (+0.05) | |
| Feb 27, 2026 | 2025 (Q4) | 0.160.19 | 0.11 | 75.00% (+0.08) | |
| Oct 30, 2025 | 2025 (Q3) | 0.120.15 | 0.14 | 6.25% (+0.01) | |
| Aug 05, 2025 | 2025 (Q2) | 0.160.22 | 0.14 | 56.25% (+0.08) | |
| May 02, 2025 | 2025 (Q1) | 0.130.19 | 0.12 | 50.00% (+0.06) | |
| Feb 28, 2025 | 2024 (Q4) | 0.140.11 | 0.12 | -14.29% (-0.02) | |
| Nov 08, 2024 | 2024 (Q3) | 0.120.14 | 0.17 | -15.79% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
